Product Information

METOPROLOL SUCC ER 200 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.1870 per EA under NDC 69097040907. Its NADAC has been published 369 times since Jul 31, 2019.

FDA first approved this application on Oct 26, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METOPROLOL SUCC ER 200 MG TAB

metoprolol succinate
$0.1870per EA

Strength

200 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097040907

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

METOPROLOL SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA207465

FDA Approved

10/26/2018

TE Code

AB

On Market Since

3/25/2019

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for METOPROLOL SUCC ER 200 MG TAB has been published 369 times since Jul 31, 2019, and over the history we have for it it has declined 66.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1870 per EA
All-time high$0.5573 (Aug 14, 2019)
All-time low$0.1284 (Nov 20, 2024)
52-week high$0.1997
52-week low$0.1588
Median price$0.2146
Average price$0.2728
Largest weekly change+48.9% (Aug 23, 2023)
Weeks tracked369
Tracking sinceJul 31, 2019

Price History

1W

+0.6%

1M

+0.6%

3M

+7.8%

6M

+2.7%

1Y

+7.3%

3Y

+9.0%

5Y

-51.0%

All

-66.4%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METOPROLOL SUCC ER 200 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 200 MG TAB, manufactured by Cipla USA Inc., is $0.1870 per EA (NDC 69097040907), effective Aug 19, 2026.

How has the price of METOPROLOL SUCC ER 200 MG TAB changed over time?

Over the history we have for it, the NADAC for METOPROLOL SUCC ER 200 MG TAB has declined 66.4%. It has been tracked across 369 weekly CMS publications since Jul 31, 2019.

What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 200 MG TAB?

Since Jul 31, 2019, the NADAC for METOPROLOL SUCC ER 200 MG TAB has ranged from a low of $0.1284 (Nov 20, 2024) to a high of $0.5573 (Aug 14, 2019), with a median of $0.2146 per EA.

Are there cheaper alternatives to METOPROLOL SUCC ER 200 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOPROLOL SUCC ER 200 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures METOPROLOL SUCC ER 200 MG TAB?

METOPROLOL SUCC ER 200 MG TAB (NDC 69097040907) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.